|
1
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sanai N, Alvarez-Buylla A and Berger MS:
Neural stem cells and the origin of gliomas. N Engl J Med.
353:811–822. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Louis DN, Perry A, Wesseling P, Brat DJ,
Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM,
Reifenberger G, et al: The 2021 WHO Classification of tumors of the
central nervous system: A summary. Neuro Oncol. 23:1231–1251. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sejda A, Grajkowska W, Trubicka J,
Szutowicz E, Wojdacz T, Kloc W and Iżycka-Świeszewska E: WHO CNS5
2021 classification of gliomas: A practical review and road signs
for diagnosing pathologists and proper patho-clinical and
neuro-oncological cooperation. Folia Neuropathol. 60:137–152. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Eckel-Passow JE, Lachance DH, Molinaro AM,
Walsh KM, Decker PA, Sicotte H, Pekmezci M, Rice T, Kosel ML,
Smirnov IV, et al: Glioma Groups Based on 1p/19q, IDH, and TERT
promoter mutations in tumors. N Engl J Med. 372:2499–2508. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Louis DN, Wesseling P, Aldape K, Brat DJ,
Capper D, Cree IA, Eberhart C, Figarella-Branger D, Fouladi M,
Fuller GN, et al: cIMPACT-NOW update 6: New entity and diagnostic
principle recommendations of the cIMPACT-Utrecht meeting on future
CNS tumor classification and grading. Brain Pathol. 30:844–856.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Davis ME: Epidemiology and overview of
gliomas. Semin Oncol Nurs. 34:420–429. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Cáceres JF and Krainer AR: Functional
analysis of pre-mRNA splicing factor SF2/ASF structural domains.
EMBO J. 12:4715–4726. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zuo P and Manley JL: Functional domains of
the human splicing factor ASF/SF2. EMBO J. 12:4727–4737. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Das S and Krainer AR: Emerging functions
of SRSF1, splicing factor and oncoprotein, in RNA metabolism and
cancer. Mol Cancer Res. 12:1195–1204. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Paz S, Ritchie A, Mauer C and Caputi M:
The RNA binding protein SRSF1 is a master switch of gene expression
and regulation in the immune system. Cytokine Growth Factor Rev.
57:19–26. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen L, Luo C, Shen L, Liu Y, Wang Q,
Zhang C, Guo R, Zhang Y, Xie Z, Wei N, et al: SRSF1 Prevents DNA
damage and promotes tumorigenesis through regulation of DBF4B
Pre-mRNA splicing. Cell Rep. 21:3406–3413. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Anczuków O, Rosenberg AZ, Akerman M, Das
S, Zhan L, Karni R, Muthuswamy SK and Krainer AR: The splicing
factor SRSF1 regulates apoptosis and proliferation to promote
mammary epithelial cell transformation. Nat Struct Mol Biol.
19:220–228. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lv Y, Zhang W, Zhao J, Sun B, Qi Y, Ji H,
Chen C, Zhang J, Sheng J, Wang T, et al: SRSF1 inhibits autophagy
through regulating Bcl-x splicing and interacting with PIK3C3 in
lung cancer. Signal Transduct Target Ther. 6:1082021. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Das T, Lee EY, You HJ, Kim EE and Song EJ:
USP15 and USP4 facilitate lung cancer cell proliferation by
regulating the alternative splicing of SRSF1. Cell Death Discov.
8:242022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu J, Yuan JF and Wang YZ:
METTL3-stabilized lncRNA SNHG7 accelerates glycolysis in prostate
cancer via SRSF1/c-Myc axis. Exp Cell Res. 416:1131492022.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou X, Wang R, Li X, Yu L, Hua D, Sun C,
Shi C, Luo W, Rao C, Jiang Z, et al: Splicing factor SRSF1 promotes
gliomagenesis via oncogenic splice-switching of MYO1B. J Clin
Invest. 129:676–693. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Broggi G, Barbagallo D, Lacarrubba F,
Verzì AE, Micali G, Purrello M and Caltabiano R: The
immunohistochemical expression of the serine and arginine-rich
splicing factor 1 (SRSF1) is a predictive factor of the recurrence
of basal cell carcinoma: A preliminary study on a series of 52
cases. Medicina (Kaunas). 58:1392022. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brat DJ, Prayson RA, Ryken TC and Olson
JJ: Diagnosis of malignant glioma: Role of neuropathology. J
Neurooncol. 89:287–311. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Weller M, van den Bent M, Preusser M, Le
Rhun E, Tonn JC, Minniti G, Bendszus M, Balana C, Chinot O, Dirven
L, et al: EANO guidelines on the diagnosis and treatment of diffuse
gliomas of adulthood. Nat Rev Clin Oncol. 18:170–186. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Broggi G, Salvatorelli L, Barbagallo D,
Certo F, Altieri R, Tirrò E, Massimino M, Vigneri P, Guadagno E,
Maugeri G, et al: Diagnostic utility of the immunohistochemical
expression of serine and arginine rich splicing factor 1 (SRSF1) in
the differential diagnosis of adult gliomas. Cancers (Basel).
13:20862021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu J, Ni X, Yu Z, Wu S and Liu Z: CRNDE
inducing cisplatin resistance through SRSF1/TIA1 signaling pathway
in ovarian cancer. Pathol Res Pract. 235:1539572022. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li J, Han T, Li Z, Han H, Yin Y, Zhang B,
Zhang H and Li L: A Novel circRNA hsa_circRNA_002178 as a
diagnostic marker in hepatocellular carcinoma enhances cell
proliferation, invasion, and tumor growth by stabilizing SRSF1
expression. J Oncol. 2022:41840342022.PubMed/NCBI
|
|
24
|
Salifu SP and Doughan A: New clues to
prognostic biomarkers of four hematological malignancies. J Cancer.
13:2490–2503. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tejada S, Becerra-Castro MV, Nuñez-Cordoba
J and Díez-Valle R: Ki-67 proliferative activity in the tumor
margins as a robust prognosis factor in glioblastoma patients. J
Neurol Surg A Cent Eur Neurosurg. 82:53–58. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhao A and Liu Y: Propofol suppresses
colorectal cancer development by the circ-PABPN1/miR-638/SRSF1
axis. Anal Biochem. 631:1143542021. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Barbagallo D, Caponnetto A, Brex D,
Mirabella F, Barbagallo C, Lauretta G, Morrone A, Certo F, Broggi
G, Caltabiano R, et al: CircSMARCA5 Regulates VEGFA mRNA splicing
and angiogenesis in glioblastoma multiforme through the binding of
SRSF1. Cancers (Basel). 11:1942019. View Article : Google Scholar : PubMed/NCBI
|
